Tag Archives: LXRP

Top Value Stocks To Buy Right Now

ValuEngine upgraded shares of MasTec (NYSE:MTZ) from a sell rating to a hold rating in a research note released on Thursday.

Several other equities analysts have also recently issued reports on the company. Robert W. Baird raised MasTec from a neutral rating to an outperform rating and set a $51.00 price objective for the company in a report on Tuesday, August 7th. Credit Suisse Group decreased their price objective on MasTec from $70.00 to $64.00 and set an outperform rating for the company in a report on Wednesday, May 2nd. Zacks Investment Research cut MasTec from a buy rating to a hold rating in a report on Wednesday, July 4th. Finally, Canaccord Genuity reissued a buy rating and issued a $65.00 price objective on shares of MasTec in a report on Friday, August 3rd. Two research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. MasTec has an average rating of Buy and an average target price of $60.08.

Top Value Stocks To Buy Right Now: Lexaria Bioscience (LXRP)

Advisors’ Opinion:

  • [By ]

    Lexaria Bioscience (OTCQX:LXRP) so a brief update.

    The two most significant items are an increase in their patent portfolio and testing of their DehydraTECH technology for nicotine. As mentioned above, the tobacco industry is much larger than marijuana.

  • [By ]

    Here is the list of the cannabis companies that we track.

    Name Currency Ticker Canopy Growth Corp. CAD (CGC) Aurora Cannabis Inc. CAD (ACBFF) Aphria Inc. CAD (APHQF) MedReleaf Corp. CAD (OTCPK:MEDFF) Cronos Group CAD (CRON) The Green Organic Dutchman CAD (OTC:TGODF) CannTrust CAD (OTC:CNTTF) Hydropothecary Corp/The CAD (HYYDF) Cannabis Wheaton Income CAD (OTCQB:CBWTF) Emerald Health Therapeutics Inc. CAD (OTCQX:EMHTF) Organigram Holdings Inc. CAD (OTCQB:OGRMF) TerrAscend Corp. CAD (OTC:TRSSF) Supreme Cannabis Co Inc./The CAD (OTCPK:SPRWF) Hiku Brands CAD (OTCPK:DJACF) ABcann Global Corp. CAD (OTCQB:ABCCF) Radient Technologies Inc. CAD (OTC:RDDTF) Village Farms International Inc. CAD (OTCQX:VFFIF) Namaste Technologies CAD (OTCQB:NXTTF) MPX Bioceutical Corp. CAD (OTCQB:MPXEF) Sunniva CAD (OTCQX:SNNVF) MYM Nutraceuticals Inc. CAD (OTCQB:MYMMF) Maricann Group Inc. CAD (OTCQB:MRRCF) Cannabix Technologies Inc. CAD (OTCPK:BLOZF) THC Biomed INTL. Ltd. CAD (OTCQB:THCBF) ICC Labs Inc. CAD (OTC:ICCLF) WeedMD Inc. CAD (OTCPK:WDDMF) CannaRoyalty Corp. CAD (OTCQX:CNNRF) InMed Pharmaceuticals Inc. CAD (OTCQX:IMLFF) Harvest One Cannabis Inc. CAD (OTC:HRVOF) Golden Leaf Holdings Inc. CAD (OTCQB:GLDFF) Benchmark Botanics Inc. CAD (OTCPK:BHHKF) Friday Night Inc. CAD (OTCQB:TGIFF) Valens Groworks Corp. CAD (OTC:MYMSF) Invictus MD CAD (IVITF) Emblem Corp. CAD (OTCPK:EMMBF) Tetra Bio-Pharma Inc. CAD (OTCQB:TBPMF) Maple Leaf Green World Inc. CAD (OTCQB:MGWFF) Delta 9 Cannabis Inc. CAD (OTC:VRNDF) Nutritional High International Inc. CAD (OTCQB:SPLIF) Lifestyle Delivery Systems Inc. CAD (OTCQX:LDSYF) Marapharm Ventures Inc. CAD (OTCQX:MRPHF) Wildflower Marijuana Inc. CAD (OTC:WLDFF) Indiva Ltd. CAD (OTC:RMKXD) Hempco Food And Fiber Inc. CAD (OTC:HMPPF) PUF Ventures Inc. CAD (OTCPK:PUFXF) Liberty Leaf Holdings CAD (OTCQB:LIBFF) Canada House Welln

Top Value Stocks To Buy Right Now: Weatherford International plc(WFT)

Advisors’ Opinion:

  • [By Paul Ausick]

    Weatherford International plc (NYSE: WFT) traded down about 3.7% Tuesday and match a 52-week low of $2.08 after closing Monday at $2.16. The stock’s 52-week high is $6.86. Volume was about 10% below the daily average of around 23.7 million shares. The company had no specific news.

  • [By Max Byerly]

    Weatherford International plc (NYSE:WFT) Director William E. Macaulay sold 767,591 shares of the stock in a transaction dated Friday, August 24th. The shares were sold at an average price of $2.86, for a total value of $2,195,310.26. Following the completion of the transaction, the director now directly owns 399,443 shares in the company, valued at $1,142,406.98. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

  • [By Jason Hall]

    Shares of Weatherford International plc (NYSE:WFT) finished trading down 12.4% on March 6. Unlike many typical big-moving days for stocks, there wasn’t any news out today to explain the big sell-off. The company didn’t issue any press releases or file anything with the SEC. 

Top Value Stocks To Buy Right Now: iShares S&P India Nifty 50 Index Fund(INDY)

Advisors’ Opinion:

  • [By Max Byerly]

    Jane Street Group LLC bought a new stake in shares of iShares India 50 ETF (NASDAQ:INDY) in the 2nd quarter, HoldingsChannel reports. The firm bought 52,309 shares of the company’s stock, valued at approximately $1,841,000.

Top 5 High Tech Stocks To Invest In 2019

Chairman, President and CEO of First Internet Bancorp (NASDAQ:INBK) David B Becker bought 5,000 shares of INBK on 09/20/2017 at an average price of $30.02 a share. The total cost of this purchase was $150,100.

First Internet Bancorp is a bank holding company that conducts its business activities through its subsidiary, First Internet Bank of Indiana. It offers Residential Mortgage, Consumer, Commercial Real Estate & Commercial and Industrial Lending. First Internet Bancorp has a market cap of $201.920 million; its shares were traded at around $31.00 with a P/E ratio of 13.85 and P/S ratio of 3.25. The dividend yield of First Internet Bancorp stocks is 0.77%. First Internet Bancorp had annual average EBITDA growth of 13.90% over the past five years.

CEO Recent Trades:

Chairman, President and CEO David B Becker bought 5,000 shares of INBK stock on 09/20/2017 at the average price of $30.02. The price of the stock has increased by 3.26% since.

Directors and Officers Recent Trades:

Top 5 High Tech Stocks To Invest In 2019: Lexaria Bioscience (LXRP)

Advisors’ Opinion:

  • [By Jim Robertson]

    In October, small cap food sciences stockLexaria Bioscience Corp (OTCQB: LXRP) was issuedU.S. Patent No. 9,474,725 Cannabinoid Infused Food and Beverage Compositions and Methods of Use Thereof and now the company is seeking to expand this patent internationally. This patent protects Lexaria Bioscience Corps intellectual property related to infusion of cannabinoid compounds in edible products and includes a set of claims that describe the Companys method of combining a fatty acid compound with any non-psychoactive cannabinoid for improved bioavailability and taste performance in both food and beverage formats.

  • [By James E. Brumley]

    Are hemp and marijuana one and the same? It depends who you ask. The federal government accurately recognizes that hemp and marijuana are variants of the same species, Cannabis sativa. Yet, poodles and German shepherds are also from the same species, and the two couldn’t be any more different types of dogs. The same goes for marijuana and hemp. The difference between hemp and marijuana is primarily the amount of tetrahydrocannabinol (or THC), which is the primary psychoactive chemical in marijuana. Hemp contains less than 0.5% THC, while marijuana consists of anywhere from 6 % to 20% (and sometimes more) THC.

    The good news is, governments – federal and state – are finally starting to wise up to the distinct differences between marijuana and hemp, and that bodes well for a young startup called Lexaria Bioscience Corp (OTCMKTS:LXRP).

    Lexaria Bioscience Corp. is “a food biosciences company with a proprietary technology for improved delivery of bioactive compounds. The Company’s lipophilic enhancement technology has been shown to enhance the bioavailability of orally ingested cannabinoids, while also masking taste. This technology promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery. The Company’s technology is patent-protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids, and patent-pending for Tetrahydrocannabinol (THC), other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.”

    In other words, it solves a problem within the budding (no pun intended) world of cannabis and medical — or even recreational — marijuana. It increases the amount of absorption of a substance ingested.

    The science has applications in everything from vitamins to supplements to painkillers, but LXRP is starting with the hemp oil for good reason.

    Hemp seeds (which are technically a nut and are als

  • [By Bryan Murphy]

    At first glance, it looks like it could be trouble for Lexaria Bioscience Corp (OTCMKTS:LXRP). That is, on Wednesday, the nation’s Drug Enforcement Agency brought clarity to a rule that had been up in the air since 2011. That is, in short, the DEA’s position on all cannabis extracts, including CBD oil, is that they are all federally illegal Schedule I substances.

    From a legal and logical standpoint based just on the DEA’s language published in the Federal Register yesterday, that puts Lexaria Bioscience in jeopardy. Lexaria has developed a way to improve the body’s absorption of hemp oil — which is deliberately high in cannabidiol/CBD — which was perfectly legal and legitimate since THC percentage in hemp (0.3%or less) are technically legal. Now the federal government’s drug-enforcement arm says that’s not the case. The newly-clarified law defines the illegal substance as “extracts that have been derived from any plant of the genus Cannabis and which contain cannabinols and cannabidiols.” Hemp, even though it’s not marijuana, is of the Cannabis genus.

    Bad news for LXRP owners? Not quite, for a handful of reasons.

    The decision (which bypassed legislature and overstepped the DEA’s authority, by the way – more on that in a second) is evidence of a long-standing problem the government agency has had in dealing with hemp and cannabis. In simplest terms, the DEA has operated and acted as if it has no real understanding of the difference between hemp and marijuana. They are of the same genus, but not of the same species. Moreover, while the former predominantly contains cannabidiol, the latter is sought out for its high tetrahydrocannabinol (or THC) for the purpose of creating a “high.”

    Problem (for the DEA): The U.S. judicial system has already ruled that the DEA doesn’t have the authority to make such rules.

    Attorney Robert Hoban explained yesterday evening at industry website newcannabisventures.com:

  • [By Matthew Briar]

    Earlier this month, some light was shed on the so-called marijuana ‘zombie’ outbreak in Brooklyn (and a handful of other places) earlier this year. As it turns out, it wasn’t a zombie outbreak at all… not that anyone really suspected the undead were lurking about. The culprit was drugs, or more specifically, chemicals and compounds that serve as drugs that weren’t meant to be utilized in that manner. In the search for a stronger, more intense high, marijuana fans got far more than they bargained for, and not in good way.

    The matter inadvertently puts an up-and-coming company called Lexaria Bioscience Corp (OTCMKTS:LXRP) in the spotlight. See, Lexaria Bioscience could have sidestepped the zombie-like response of what’s now clearly been deemed a chemical-laced plant nobody would ever actually choose to smoke if they knew better. How so? Because LXRP could have provided the more intense ‘high’ being sought using its infusion science and real marijuana… not the synthetic marijuana that’s been causing unexpected results like hallucinations, extreme agitation, a rapid heartbeat and extremely high blood pressure. paranoia, anxiety, panic attacks and psychotic episodes. Those aren’t the usual responses to weed. They’re common responses to other, harsher narcotics, and are often wished avoided by recreational marijuana users.

    Say what you want about the moral hazards or dangers of legalized marijuana, but nobody can deny that it’s happening… in the United States, and abroad. In November, marijuana was on the ballot for one reason or another in nine states, and the pro-marijuana movement got the green light in eight of them. Weed is now legal, either for medicinal or recreational use, in more than half the states that make up the U.S.A.

    More relevant to the matter at hand, in step with the ongoing legalization of marijuana, users and sellers have — as they always do– pushed the limits of legality and science to come up with a better expe

Top 5 High Tech Stocks To Invest In 2019: Liberty Interactive Corporation(QVCA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    QVC (QVCA) was upgraded to buy from neutral at Bank of America/Merrill Lynch. $25 price target. The company can turn its sales around and deserves a higher multiple, analysts said. 

Top 5 High Tech Stocks To Invest In 2019: J & J Snack Foods Corp.(JJSF)

Advisors’ Opinion:

  • [By Monica Gerson]

    J & J Snack Foods Corp (NASDAQ: JJSF) is estimated to post its quarterly earnings at $0.78 per share on revenue of $231.58 million.

    Nabors Industries Ltd. (NYSE: NBR) is expected to post a quarterly loss at $0.33 per share on revenue of $630.85 million.

Top 5 High Tech Stocks To Invest In 2019: Allegheny Technologies Incorporated(ATI)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market performed well on Tuesday, responding to steady improvement among many companies as earnings season kicked into high gear. Although political issues are likely to remain in the spotlight for some investors for the foreseeable future, many market participants are looking to economic and business issues in driving their investing decisions. Major market benchmarks finished the day with gains of 0.5% to 1%, but some stocks did much better. Among the best performers on the day were Allegheny Technologies (NYSE:ATI), II-VI (NASDAQ:IIVI), and Beazer Homes (NYSE:BZH). Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By Lisa Levin]

    Tuesday morning, the basic materials shares climbed by 0.95 percent. Meanwhile, top gainers in the sector included Allegheny Technologies Incorporated (NYSE: ATI), up 5 percent, and Mechel PAO (ADR) (NYSE: MTL), up 5 percent.

Top 5 High Tech Stocks To Invest In 2019: Barclays PLC(BCS)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Investors are becoming increasingly bullish about BTC, as financial institutions like Barclays Plc. (NYSE: BCS) become more interested in entering the cryptocurrency market.

  • [By Jon C. Ogg]

    Barclays PLC (NYSE: BCS) was raised to Overweight from Equal Weight at Morgan Stanley. Its American depositary sharesclosed up 2.6% at $11.36 on Thursday and were indicated up 1.2% at $11.50 on Friday. The52-week range is $6.76 to $12.05.

  • [By WWW.THESTREET.COM]

    Banco Santander (SAN) : “I prefer Barclays (BCS) , but let’s wait and see what the other banks have to say”

    ProLogis (PLD) : “I am not a fan of that group right now, but that one is best of breed.”

  • [By Garrett Baldwin]

    Some of this sentiment has been fueled by optimism that UK investment bank Barclays Plc. (NYSE: BCS) is looking to open a cryptocurrency trading desk in the months ahead.

Best Stocks To Buy For 2019

5 LTC Thoughts From a Top Nationwide Executive

4 Key Buy-Sell Agreement Basics

3 Ways Alabama’s New Senator Could Affect Agents

Providing good contact center service for annuity holders is more difficult today than it used to be 22 years ago.

Brendan Yeager, a service quality specialist at Dalbar, gave that assessment Thursday, in an annuity service award announcement put out by Dalbar.

Dalbar, a Boston-based financial services communication consulting firm, gave its 2017 Annuity Service Award to four annuity issuers: AXA Equitable; AIG Individual Retirement; Guardian Retirement Contact Center; and Transamerica Annuities

(Related: Investment Salespeople Are Underrated)

Typical annuity contact center questions are getting tougher because consumers can now use the web to get answers to simple questions, Yeager said.

When Dalbar began giving out annuity service awards, in 1995, many consumers were calling annuity contact centers to ask about simple matters, such as account values, Yeager said

Best Stocks To Buy For 2019: Fossil Inc.(FOSL)

Advisors’ Opinion:

  • [By Paul Ausick]

    Fossil Group Inc. (NASDAQ: FOSL) dropped nearly 21% Wednesday, to post a new 52-week low of $18.10 after closing at $22.87 on Tuesday. The stock’s 52-week high is $51.93. Volume was about 15 times the daily average of around 1.2 million shares. The company reported so-so results last night and Wells Fargo cut its rating on the stock to Underperform this morning.

  • [By WWW.THESTREET.COM]

    Fossil is in deep trouble: As mentioned earlier in the week, Fossil (FOSL) came out with more big plans for the smartwatch market at Basel World. Unfortunately, as TheStreet reported, the company is fighting an uphill battle with Apple and could be in big trouble. 

  • [By Lisa Levin]

    Fossil Group Inc (NASDAQ: FOSL) was down, falling around 21 percent to $14.32 after the company posted downbeat quarterly results and issued a weak outlook for the second quarter.

Best Stocks To Buy For 2019: Royal Dutch Shell PLC(RDS.A)

Advisors’ Opinion:

  • [By Dustin Parrett]

    Specifically, the oil supermajors are ExxonMobil Corp. (NYSE: XOM), BP Plc. (NYSE: BP), Chevron Corp. (NYSE: CVX), Royal Dutch Shell Plc. (NYSE ADR: RDS.A), Conoco Phillips (NYSE: COP), Eni SpA (NYSE ADR: E), and Total SA (NYSE ADR: TOT).

  • [By Dustin Parrett]

    Big Oil stocks are the seven “oil supermajors” that do everything from oil drilling to refining to retail sales. This is a list of the Big Oil companies:

    Big Oil CompanyShare PriceYTDMarket CapExxon Mobil Corp. (NYSE: XOM)$83.44-7.58%$353.13BChevron Co. (NYSE: CVX)$113.56-3.5%$217.62BConocoPhillips Co. (NYSE: COP)$48.21-3.78%$61.42BRoyal Dutch Shell Plc. (NYSE ADR: RDS.A)$52.35-3.82%$221.08BBP Plc. (NYSE ADR: BP)$34.12-8.71%$112.69BTotal SA (NYSE: TOT)$50.26-1.35%$124.6BEni SpA (NYSE: E)$31.51-2.3%$58.69B

    Despite being huge global oil companies, shares of Big Oil stocks are all in the red this year. Those losses have all happened even as the Dow is smashing record highs and trading up 6.4% year to date.

  • [By WWW.THESTREET.COM]

    Global oil prices nudged higher Monday even amid reports that Royal Dutch Shell (RDS.A) is re-starting a key Houston refinery that was shuttered by Hurricane Harvey three weeks ago.

Best Stocks To Buy For 2019: Lexaria Bioscience (LXRP)

Advisors’ Opinion:

  • [By Bryan Murphy]

    In the grand scheme of things it shouldn’t be surprising, though odds are good at least a few people are surprised at how quickly it happened. That is, health supplement and healthy-foods brand name NeutriSci International Inc (CVE:NU) and the developer of a cannabis-infusion technology — a means of packing more CBD into hemp oil — called Lexaria Bioscience Corp (OTCMKTS:LXRP) have finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.

    The benefits of cannabidiol, found in hemp and marijuana, are relatively well understood by the market at this point. Cannabidiol can do a human body a lot of good, like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more. Pterostilbene is the lesser-known of the two components of the new tablet, but no less impressive and no less beneficial. Pterostilbene is known to combat high cholesterol, high blood pressure, and oxidative stress. Combining the two is a real one-two punch for the health-conscious.

    That’s what made November’s news so exciting… NeutriSci International has an established name and marketing channel, while Lexaria Bioscience has the science that makes hemp oil far more functional. Indeed, to fully appreciate the upside for LXRP, one has to embrace Lexaria’s science and why it matters.

    The bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short,

  • [By Jim Robertson]

    In October, small cap food sciences stockLexaria Bioscience Corp (OTCQB: LXRP) was issuedU.S. Patent No. 9,474,725 Cannabinoid Infused Food and Beverage Compositions and Methods of Use Thereof and now the company is seeking to expand this patent internationally. This patent protects Lexaria Bioscience Corps intellectual property related to infusion of cannabinoid compounds in edible products and includes a set of claims that describe the Companys method of combining a fatty acid compound with any non-psychoactive cannabinoid for improved bioavailability and taste performance in both food and beverage formats.

  • [By Bryan Murphy]

    At first glance, it looks like it could be trouble for Lexaria Bioscience Corp (OTCMKTS:LXRP). That is, on Wednesday, the nation’s Drug Enforcement Agency brought clarity to a rule that had been up in the air since 2011. That is, in short, the DEA’s position on all cannabis extracts, including CBD oil, is that they are all federally illegal Schedule I substances.

    From a legal and logical standpoint based just on the DEA’s language published in the Federal Register yesterday, that puts Lexaria Bioscience in jeopardy. Lexaria has developed a way to improve the body’s absorption of hemp oil — which is deliberately high in cannabidiol/CBD — which was perfectly legal and legitimate since THC percentage in hemp (0.3%or less) are technically legal. Now the federal government’s drug-enforcement arm says that’s not the case. The newly-clarified law defines the illegal substance as “extracts that have been derived from any plant of the genus Cannabis and which contain cannabinols and cannabidiols.” Hemp, even though it’s not marijuana, is of the Cannabis genus.

    Bad news for LXRP owners? Not quite, for a handful of reasons.

    The decision (which bypassed legislature and overstepped the DEA’s authority, by the way – more on that in a second) is evidence of a long-standing problem the government agency has had in dealing with hemp and cannabis. In simplest terms, the DEA has operated and acted as if it has no real understanding of the difference between hemp and marijuana. They are of the same genus, but not of the same species. Moreover, while the former predominantly contains cannabidiol, the latter is sought out for its high tetrahydrocannabinol (or THC) for the purpose of creating a “high.”

    Problem (for the DEA): The U.S. judicial system has already ruled that the DEA doesn’t have the authority to make such rules.

    Attorney Robert Hoban explained yesterday evening at industry website newcannabisventures.com:

Best Stocks To Buy For 2019: Exterran Corporation(EXTN)

Advisors’ Opinion:

  • [By Dustin Parrett]

    Company Name

    Share PriceYTDMarket CapClayton Williams Energy Inc. (NYSE: CWEI)$138.8216.4%2.4BDiamondback Energy Inc. (Nasdaq: FANG)$106.365.42%$9.38BWestern Gas Partners LP (NYSE: WES)$65.6411.71%$9.67BTesoro Logistics LP (NYSE: TLLP)$59.3416.79%$6.25BResolute Energy Corp. (NYSE: REN)$46.0811.87%$931.13MAntero Midstream Partners LP (NYSE: AM)$34.9813.28%$6.4BExterran Corp. (NYSE: EXTN)$33.9942.22%$1.19BDominion Midstream Partners LP (NYSE: DM)$32.9011.34%$2.6BNextEra Energy Partners LP (NYSE: NEP)$31.1922.12%$1.68BArchrock Inc. (NYSE: AROC)$16.0021.21%$1.12B

    While some of these stocks have performed well, we arent recommending this list of natural gas stocks. Thats because we arent interested in stocks that have already peaked at Money Morning; were interested in the next big winner. And we have one that could surge in 2017